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The complexity of organogenesis hinders in vitro
generation of organs derived fromapatient’s pluripo-
tent stem cells (PSCs), an ultimate goal of regenera-
tive medicine. Mouse wild-type PSCs injected into
Pdx1/ (pancreatogenesis-disabled) mouse blasto-
cysts developmentally compensated vacancy of
the pancreatic ‘‘developmental niche,’’ generating
almost entirely PSC-derived pancreas. To examine
the potential for xenogenic approaches in blastocyst
complementation,we injectedmouseor ratPSCs into
rat or mouse blastocysts, respectively, generating
interspecific chimeras and thus confirming that
PSCs can contribute to xenogenic development
between mouse and rat. The development of these
mouse/rat chimeras was primarily influenced by
host blastocyst and/or foster mother, evident by
body size and species-specific organogenesis. We
further injected rat wild-type PSCs into Pdx1/
mouse blastocysts, generating normally functioning
rat pancreas in Pdx1/ mice. These data constitute
proof of principle for interspecific blastocyst comple-
mentationand for generation in vivooforgansderived
from donor PSCs using a xenogenic environment.INTRODUCTION
Current stem cell therapy mainly targets diseases that can be
treated by cell replacement, such as Parkinson’s disease or dia-
betes mellitus. One of the ultimate goals of regenerative medi-
cine, however, is to grow organs using the patient’s own stemcells and to transplant those organs into the patient. With the
development of induced pluripotent stem cell (iPSC) technology,
we are now able to obtain patient-derived PSCs (Takahashi
et al., 2007; Takahashi and Yamanaka, 2006), although actual
developmental potentials remain to be defined, as do risks asso-
ciated with somatic cell reprogramming. The real challenge is to
create a reproductive system for generation of PSC-derived
organs. The interactions among cells and tissues during devel-
opment and organogenesis are so complex that the recapitula-
tion of these interactions to generate organs in vitro is essentially
impractical. We have challenged this goal using the biology of
blastocyst complementation.
Blastocyst complementation was first reported by Chen et al.
They demonstrated that deficiency of T and B lymphocyte
lineages in Rag2-deficient (Rag2/) mice was complemented
by injecting normal mouse embryonic stem cells (mESCs) into
Rag2/ mouse-derived blastocysts (Chen et al., 1993).
Because Rag2 is an indispensable enzyme for rearrangement
of immunoglobulin and T cell receptor genes, the T and B cells
generated in the complemented animals were mESC derived;
there were no host T or B lymphocytes. We assumed that this
complementation was possible because the Rag2/ host, inca-
pable of generating mature T and B cells, provided a ‘‘develop-
mental niche’’ for ESC-derived T and B cells.
We hypothesized that with blastocysts derived from a mutant
mouse strain in which the gene necessary to form a particular
organ is deficient, the same principle might apply. To test
this hypothesis, we used, in this study, blastocyst complementa-
tion to generate functional pancreas from donor PSCs. The
pancreas, consisting of endocrine andexocrineglands, is formed
by early embryonic interactions of mesenchyme and epithelium
(Slack, 1995). Pdx1 (pancreatic and duodenal homeobox1) is
a Hox-type transcription factor that plays a critical role in pancre-
atic development and b cell maturation. Homozygous deficiency
of Pdx1 in the mouse results in death soon after birth due toCell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc. 787
pancreatic insufficiency (Offield et al., 1996). Targeted disruption
of Pdx1 thus should empty a pancreatic ‘‘developmental niche’’
in embryos derived from Pdx1/ blastocysts. Therefore, injec-
tion of mouse PSCs (mPSCs) into Pdx1/ blastocysts should
result in generation of pancreata almost entirely derived from
injected mPSCs.
Although our results verified our initial hypothesis, this system
cannot be applied to generate human organs. A xenogenic, but
not allogenic, blastocyst complementation system must there-
fore be established. However, little is known about the nature
of the xenogenic barrier, how organogenesis by donor PSCs is
influenced, or how intrinsic developmental programs can be
regulated in xenogenic environments. To address these issues,
we attempted to generate interspecific chimeras between
mouse and rat using a blastocyst injection technique with mouse
and rat PSCs.
Generation of interspecific chimeras in livestock animals using
preimplantation embryos of each species is described; the
‘‘geep,’’ or chimera between goat and sheep, is famous as an
interspecific live chimera (Fehilly et al., 1984). In rodents,
however, methods like those producing the geep succeeded
only between mouse subspecies, such as Mus musculus and
Mus caroli, that are closely related but not capable of inter-
breeding (Rossant and Frels, 1980). Many groups have sought
to generate interspecific chimeras between mouse and rat,
successful with chimeric preimplantation embryos in vitro but
failing with live chimeric animals (Stern, 1973; Zeilmaker,
1973). Extraembryonic lineage cells like trophectoderm or prim-
itive endoderm, derived from xenogenic embryos, might suffer
inhibition of implantation on exposure to host uterus; inhibition
of further intrauterine development also is possible (Rossant
et al., 1982; Tarkowski, 1962). Only cells of pre-blastocyst origin
can contribute to extraembryonic lineage cells, and mESCs/
iPSCs do not thus contribute (Rossant, 2007). Therefore, we
rechallenged this old issue with new technology, using iPSCs
or ESCs that are not capable of contributing to extraembryonic
tissues. Using recently established culture conditions with a
combination of signaling inhibitors (Buehr et al., 2008; Li et al.,
2008; Ying et al., 2008), we generated rat-ESCs and -iPSCs
(rESCs, riPSCs). Our work has now confirmed the existence of
interspecific chimeras generated with PSCs, using injection not
only of mouse PSCs into rat embryos but also of rat PSCs into
mouse embryos.
Finally, by combining the principle of blastocyst complemen-
tation with the production of interspecific chimeras, we suc-
ceeded in generating rat pancreas in Pdx1/ mice. These sets
of experiments provide proof-of-principle data for donor iPSC-
derived organ generation in a xenogenic environment.
RESULTS
Generation of Donor Mouse iPSC-Derived Pancreas
in Pdx1-Deficient Neonates
Our first goal was to generate pancreas from mPSCs. We per-
formed a blastocyst complementation experiment using
Pdx1/ blastocysts that would provide a niche for pancreatic
organogenesis. These mice exhibit pancreatic agenesis due to
the absence of Pdx1-specified interactions between prepancre-788 Cell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc.atic epithelium andmesenchyme, a key step in pancreatic devel-
opment. Homozygote Pdx1-LacZ knockin mice (Pdx1/) are
born alive but die within 1 week after birth, presumably due to
pancreatic insufficiency (Offield et al., 1996).
For complementation donor cells, we used GT3.2 mouse
iPSCs (miPSCs) that had been generated from tail tip fibroblasts
(TTFs) of an adult EGFP-transgenic (TG) C57BL/6 mouse (Okabe
et al., 1997) using three factors (Oct3/4, Sox2, Klf4) in retroviral
vectors (Figure S1 available online). These GT3.2 miPSCs
were injected into blastocysts obtained by an intercross of
heterozygote Pdx1-LacZ knockin mice (Pdx1+/), offspring of
C57BL/6(Pdx1+/) 3 DBA(Pdx1+/+) or C57BL/6(Pdx1+/) 3
BDF1(Pdx+/+) mice. G4.2 mESCs were also injected for compar-
ison. Neonates were assessed macroscopically and histologi-
cally for pancreatic development and were genotyped for
Pdx1. These neonates were highly chimeric: Due to silencing
of EGFP and to contamination by donor cells, accurate determi-
nation of the genotypes required analysis at the single-cell level.
To identify the genotypes of these neonates accurately, EGFP-
negative, c-Kit-positive, and Sca1-positive, lineage marker-
negative (EGFPKSL) bone marrow cells were clone-sorted by
fluorescence-activated cell sorting (FACS) to obtain single-cell-
derived hematopoietic colonies (Figure S2A). After culture for
2 weeks, cells collected from each colony were subjected to
PCR analysis (Figure S2B). This ‘‘colony PCR’’ method unambig-
uously determined the host embryo genotype and proved that
pancreas had been formed in Pdx1/ mice by blastocyst
complementation (Figure S2C).
In all postnatal chimeric mice derived from blastocysts
injected with either miPSCs or mESCs, pancreas was present
regardless of host genotype (including Pdx1/). As expected,
the pancreas in Pdx1+/ or Pdx1+/+ chimeric mice was a
composite of host-derived cells and EGFP-miPSC- or mESC-
derived cells, as in whole-body chimerism (Pdx1+/ + miPSCs
or mESCs in Figure 1A). In contrast, the pancreatic epithelium
in Pdx1/ chimeric mice was almost entirely composed of
EGFP-marked miPSC- or mESC-derived cells (Pdx1/ +
miPSCs or mESCs in Figure 1A). The pancreas of these mice
was grossly and histologically normal. We examined these
pancreatic tissues further for contributions of donor mPSCs to
different pancreatic lineages. BothmiPSCs andmESCs supplied
all pancreatic cell lineages (exocrine and endocrine tissues,
including ductal epithelia), but pancreatic stromal elements—
vessels, nerves, and fibrocytes—were composites of host- and
mPSC-derived cells in all mice (Figure 1B).
miPSCs Rescued Pdx1/ Mice by Blastocyst
Complementation
We next addressed whether mPSCs can rescue Pdx1/
lethality via blastocyst complementation. As we predicted based
on neonatal analysis (Figure 1), both mESCs and miPSCs
contributed to pancreatic organogenesis; Pdx1/ chimeric
mice survived to adulthood (mESCs injection: n = 4, miPSCs
injection: n = 15 in Figure 2A). They even served as Pdx1/
founders, transmitting their genotype to the next generation.
Mating Pdx1/ founder male mice with Pdx1+/ female mice
increased to 50% the proportion of pups of homozygously dis-
rupted genotype (Figure 2A). These data indicate that blastocyst
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(A) mPSC-derived pancreas at neonatal stage. In
Pdx1/ mice complemented with mPSCs, the pan-
creas was almost entirely positive for EGFP, indicating
mPSC origin (left panels in +miPSCs and +mESCs). On
the other hand, in Pdx1+/ mice complemented with
mPSCs, the pancreas was partially positive for EGFP,
indicating a composite of both mPSC- and host-derived
cells (right panels in +miPSCs and+mESCs). Right panel
shows absence of pancreas in a nonchimeric Pdx1/
mouse at the same developmental stage. See also
Figure S1 for detailed characteristics of miPSCs and
Figure S2 for genotyping of Pdx1 status.
(B) Histological analysis of the distribution of mESC-
derived cells in neonatal mouse pancreas. Sections of
pancreas generated in aPdx1/mouse complemented
with mESCs were immunostained for EGFP; for pancre-
atic endocrine markers (insulin, glucagon, and somato-
statin); for the pancreatic exocrine marker a-amylase;
for the ductal marker rhodamine-conjugated DBA-
lectin; and for blood vessels with PECAM-1, with DAPI
nuclear counterstaining.
Sections were observed under confocal laser scanning
microscopy. Scale bars in (B), 20 mm.complementation can be used to generate a functional organ
and to yield homozygous founder mice even when uncomple-
mented homozygosity is fatal. The method described here thus
can be useful for efficient production of gene-targeted mice
that are embryonic lethal without introducing a conditional
gene targeting system.
As expected, in both Pdx1/ and Pdx1+/ mice injected with
EGFP-miPSC, miPSC-derived cells contributed to all the non-
pancreatic tissues of the body, including lung, heart, liver,
muscle, testis, and brain (data not shown). The extent of contri-
bution varied from tissue to tissue and also varied depending on
individual chimera. However, the pancreas in adult Pdx1/mice
was entirely derived from donor miPSCs (Pdx1/ in Figure 2B).
Detailed analysis of EGFP distributions in adult miPSC-derived
pancreas demonstrated that pancreatic islets, exocrine tissues,
and duct epithelia were entirely derived from donor miPSCs, as
already shown in neonates (Pdx1/ in Figures 2C and 2D). In
expected contrast, pancreas from Pdx1+/ mice was a com-
posite of host and donor derivatives (Pdx1+/ in Figures 2B
and 2C). Quantitative analysis of these sections by image J soft-
ware revealed percentages of EGFP-positive cells to be 27.4% ±
27.8% in the miPSC + Pdx1+/ setting, 95.6% ± 4.6% in the
miPSC + Pdx1/ setting. Of note is that most individual isletsCell 142, 787–7were composed of both host-derived and
miPSC-derived cells (Pdx1+/ in Figure 2D),
indicating, as previously reported (Deltour
et al., 1991), nonclonal origin of pancreatic
islets.
To test whether miPSC-derived pancreata
are functional in Pdx1/ chimeric mice, we
performed glucose tolerance testing (GTT).
Whereas streptozotocin (STZ)-induced dia-
betic mice failed to respond to GTT, Pdx1/chimeric mice responded well, indicating that Pdx1/ mice
with miPSC-derived pancreas secreted insulin in response to
glucose loading and maintained normal serum glucose levels
(Figure 2E). Histology and function of exogenously derived
pancreas were essentially the same for mice derived from
miPSC- and frommESC-complemented blastocysts (Figure S3).
These data demonstrate that the vacant ‘‘pancreatic niche’’
provided in Pdx1/ mice can be occupied, with developmental
compensation, by miPSC- or mESC-derived cells after intraspe-
cific blastocyst complementation, generating functionally intact
pancreas.
Transplantation of miPSC-Derived Islets Corrected
Hyperglycemia in Diabetic Mice
To assess the functionality of miPSC-derived pancreas, islets
from miPSC-derived pancreas were transplanted into mice of
the original strain (C57BL/6) in which STZ administration had
induced diabetes. As a control, islets from pancreas in Pdx1+/
chimeric mice injected with miPSCs were transplanted. Blasto-
cysts were obtained by an intercross of Pdx1+/ mice (C57BL/
6 3 DBA2 or C57BL/6 3 BDF1 F1 strains) that were semi-
allogenic to miPSCs used in this study. EGFP-expressing
miPSC-derived islets (Figure 3A) were isolated conventionally99, September 3, 2010 ª2010 Elsevier Inc. 789
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Figure 2. Analysis of miPSC-Derived
Pancreas in Adult Mice: Derivation of
Pancreatic Functional Cells and Their
Response to Glucose Load
(A) Results of embryo manipulation and genotypes
of adult mice. Note that Pdx1/ mice comple-
mented with mESCs served as founders and
generated knockout mice more efficiently.
(B) Macroscopic images at adult stage
(8–12 weeks) of miPSC-derived pancreas gener-
ated in a Pdx1/ mouse (Pa in left panel) and of
composite pancreas generated in a Pdx1+/
mouse (right). In left panel, Li = liver, Pa = pancreas,
St = stomach, Sp = spleen, and Ki = kidney.
(C) Immunohistological studies of sections ob-
tained from pancreas revealed clear differences
in the distributions of miPSC-derived cells.
Sections were stained with HE or for EGFP with
DAPI nuclear counterstaining.
(D) Immunohistological analysis of a generated
islet, showing the distribution of miPSC-derived
cells. Sections were stained for EGFP, with anti-
insulin antibodies, and with DAPI nuclear counter-
staining. Yellow lines show borders of endocrine
and exocrine tissues. See also Figure S3 for anal-
ysis of mESC-derived pancreas in adult mice.
(E) Results of GTT in Pdx1/ (-) and Pdx1+/ (:)
mice (n = 6 each) complemented with miPSCs.
Micewith STZ-induced diabetes (d andA) served
as controls. Fasting after 20 hr, bloodwas sampled
via tail vein at intraperitoneal glucose administra-
tion (1 g/kg; 0 min) and 15, 30, 60, and 120 min
thereafter.
Sections in (C) were observed under fluorescence
microscopy and in (D) were observed under
confocal laser scanning microscopy. Scale bars
in (C), 100 mm; in (D), 50 mm. Error bars in (E) indi-
cate ± SD.based on a method developed previously (Gotoh et al., 1985)
and were transplanted beneath the renal capsule of recipient
mice. Nonfasting blood glucose levels were then monitored. As
these islets were of donor origin (i.e., C57BL/6 strain), an immu-
nosuppressive regimen was not used.
To prevent nonspecific loss of islets due to inflammation,
anti-inflammatory cytokine monoclonal antibody (mAb) cocktails
were given at transplantation and 2 and 4 days thereafter
(arrows, Figure 3E), as described (Satoh et al., 2007). Two
months after transplant, EGFP-expressing miPSC-derived islets
were still detectable at the graft site (Figures 3B and 3C). Produc-
tion of insulin by the transplanted islets was confirmed immuno-
histologically (Figure 3D). The induced-diabetic recipients no
longer exhibited hyperglycemia; they maintained normal blood
glucose levels and responded normally to GTT (Figures 3E
and 3F). This is in contrast to the therapeutic effect conferred
by islets, composites of blastocyst- and miPSC-derived cells,
obtained from pancreas of Pdx1+/ chimeric mice (C57BL/6 3
DBA2 or C57BL/6 3 BDF1 F1 origin). This effect lasted only for
a short time, presumably due to immune rejection by the host
C57BL/6 diabetic mice (Figure 3E). These data strongly indicate
that the miPSC-derived pancreas, with islets, formed in an allo-
genic host is functional and that the ‘‘autologous’’ islets thus
formed can be used to treat diabetes, without rejection.790 Cell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc.Blastocyst complementation thus permits demonstration of
proof-of-principle both for pancreas generation from PSCs and
for diabetic therapy using donor iPSC-derived syngenic islets.
Generation of Interspecific Chimeras between Mouse
and Rat
Our second goal was to generate interspecific chimeras
between mouse and rat. To achieve this goal, we generated
not onlymiPSCs but also riPSCs and rESCs using an established
protocol (Hirabayashi et al., 2009; Ying et al., 2008). These
mouse and rat PSCs enabled us bidirectionally to generate inter-
specific chimeras.
We injected EGFP-marked GT3.2 miPSCs into rat blastocysts
(r-blastocysts) or EGFP-marked riPSCs (Figures S4A and S4B)
into mouse blastocysts (m-blastocysts). Because post-implan-
tation development reportedly is severely hampered after intra-
uterine transfer of xenogenic blastocysts (Rossant et al., 1982;
Tarkowski, 1962), injected r-blastocysts or m-blastocysts were
transferred, respectively, into the uteri of pseudopregnant rats
or mice. After intrauterine transfer of injected r-blastocysts or
m-blastocysts with development to the fetal stage, we evaluated
EGFP expression by fluorescence microscopy for each trans-
ferred embryo. EGFP-expressing cells were found in the body
of each injected conceptus, but never in placenta (Figure 4A).
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Figure 3. Transplantation of ‘‘Autologous’’ Islets from iPSC-Derived Pancreas: A Therapeutic Model
(A) EGFP-positive islets isolated frommiPSC-derived pancreas. Via the common bile duct and pancreatic duct, miPSC-derived pancreas was perfused by colla-
genase. Density gradient centrifugation isolated a fraction enriched in EGFP-expressing islets.
(B) Kidney capsule 2 months after islet transplantation. At the site of transplantation (arrow), miPSC-derived islets still expressed EGFP.
(C) Renal subcapsular transplantation site (B, arrow); sections were stained with HE or immunostained for EGFP with DAPI nuclear counterstaining.
(D) Transplanted miPSC-derived islets in (C), immunostained for EGFP and insulin with DAPI nuclear counterstaining.
(E) Transplantation of miPSC-derived islets into mice with STZ-induced diabetes. Each mouse received 150 islets. Arrows indicate time points at which an mAb
cocktail (anti-INF-g, anti-TNF-a, anti-IL-1b) was administered. Nonfasting blood glucose levels were measured weekly for 2 months after transplantation.
Glucose levels are shown for STZ-induced diabetic mice transplanted with miPSC-derived islets (green; n = 3), with islets derived from Pdx1+/ chimeric
mice (orange; n = 2), with islets derived from syngenic strain of host strain (C57BL/6) as positive control (blue; n = 2), and with sham transplantation control
mice as negative control (purple; n = 3).
(F) Results of GTT 2 months after islet transplantation. Donors were Pdx1/ chimeric mice and Pdx1+/ chimeric mice, with blood sampling at the same time
points as in Figure 2E.
Sections in (C) were observed under fluorescence microscopy and in (D) were observed under confocal laser scanning microscopy. Scale bar in (D), 50 mm. Error
bars in (E) and (F) indicate ± SD.This finding indicates that injected mouse or rat iPSCs can
contribute to xenogenic development, with generation of inter-
specific chimeras.
Next, we tried to quantitate contribution of mouse or rat iPSCs
to these interspecific chimeras. Chimerism in interspecific
embryos appeared to vary individual-to-individual and organ-
to-organ. Since quantitation of PSC-derived cells was difficult
in organs, we analyzed embryonic fibroblasts and hematopoietic
cells. FACS analysis of embryonic fibroblasts revealed that
donor-derived EGFP+ cell percentages of about 28.0% and26.5%, respectively, were detected in mouse and rat inter-
specific chimeras (representative FACS data shown in Fig-
ure 4B). We also examined chimerism in hematopoietic cells
by staining cells from livers of interspecific chimera fetuses
with antibodies specific for mouse and rat CD45 antigens.
Cells that expressed mouse or rat CD45 represented distinct
populations in interspecific chimeras, with only cells derived
from injected iPSCs expressing EGFP (Figure 4B). Whereas
a high proportion (28.3%) of mouse blood cells was detected
in r-blastocyst-derived chimeric fetal liver, rat blood cells wereCell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc. 791
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Figure 4. Generation of Interspecific
Chimeras between Mouse and Rat
(A) Interspecific chimera fetuses generated by
injection of miPSCs into r-blastocyst (rBL: left
panels) and by injection of riPSCs into m-blasto-
cyst (mBL: right panels). With rat embryo manipu-
lation, fetuses were analyzed 12 days after embryo
transfer into uteri of 3.5 dpc pseudopregnant rats
(embryonic day (E) 15.5). With mouse embryo
manipulation, fetuses were analyzed 11 days after
embryo transfer into uteri of 2.5 dpc pseudopreg-
nant mice (E13.5). See also Figure S4 for charac-
teristics of riPSCs and interspecific embryos after
injection of riPSCs into mouse 8-cell/morula stage
embryos.
(B) Representative data of FACS analysis on cells
from fetal liver and on embryonic fibroblasts
derived from interspecific chimeras. Right panels
show cells from fetal liver immunostained with
anti-mCD45 and -rCD45 antibodies. Note that
anti-mouse or -rat monoclonal antibodies (mAb)
against CD45 can distinguish CD45-expressing
hematopoietic cells in a species-specific manner.
Almost all CD45-expressing cells derived from
injected cells express EGFP, indicating iPSC
origin.
(C) Schema of mouse and ratOct3/4 loci (mOct3/4
and rOct3/4). Of note is that in the rat Oct3/4 locus
the 2 introns flanking exon 3 are longer than in the
mouse Oct3/4 locus. This difference in length can
distinguish origins of otherwise similar cells.
Arrowheads indicate common primers of each
species for PCR. PCR product sizes for both
species are shown below.
(D) Results of genotyping to identify origin of hematopoietic cells expressing mouse or rat CD45 in fetal liver of interspecific chimeras. Peripheral-blood CD45-
expressing cells from each species served as positive controls.
(E) Correlation of chimerism between embryonic fibroblasts and CD45+ hematopoietic cells in fetal liver. Cells were prepared from interspecific chimeras gener-
ated by injection of riPSCs into m-blastocysts or from intraspecific chimeras generated by injection of riPSCs into r-blastocysts.
(F) Relative frequencies of aborted, nonchimeras, and chimeras embryonic development (E13.5 and 15.5).
(G) Chimerism analysis of embryonic fibroblasts from chimeras generated by injection of miPSCs or riPSCs into mouse or rat blastocysts. Fibroblasts were
obtained from chimeras and analyzed for EGFP intensity by FACS. Plotted dots show degrees of chimerism for individual embryos. See also Figure S5 for inter-
specific chimeras using ESCs.
Scale bars in (A), 5 mm.only rarely present (less than 3.3%) in m-blastocyst-derived
chimeric fetal liver (Figure 4B). This tendency was specific to
interspecific chimeras and not observed in intraspecific
chimeras (Figure 4E). It is not clear why the difference in contri-
bution of iPSCs to hematopoietic cells between mouse and rat
interspecific chimeras was so marked.
To further confirm interspecific chimerism, genomic DNA
extracted from FACS-sorted cells expressing CD45 was PCR-
amplified using primers common to the mouse and rat Oct3/4
loci (Figure 4C). PCR products of different lengths, indicating
origin in each species, were clearly present (Figure 4D). These
results strongly indicated that the animals harboring these cells
were mouse/rat interspecific chimeras.
To investigate the influence of iPSC contribution to xenogenic
development at the fetal stage, we assessed embryonic devel-
opment rate of interspecific chimeras, and the extent of chime-
rism, by FACS analysis using established embryonic fibroblasts.
Both embryonic development rate and degree of chimerism
were lower in interspecific chimeras than in intraspecific792 Cell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc.chimeras (Figures 4F and 4G). In addition, high contributions
by xenogenic cells appeared to be associated with morpholog-
ical abnormalities and embryonic lethality (data not shown). To
exclude the possibility that these abnormalities were caused by
donor iPSCs, we also attempted to generate interspecific
chimeras using mouse or rat ESCs. DsRed-marked EB3DR
mESCs could also generate interspecific rat chimeras (top
panels in Figure S5A), with embryonic development rate and
degree of chimerism similar to those generated by miPSC
injection (Figure S5B). The Venus-marked WIv3i-1 and -5
rESC lines, with high contribution to rat embryo development
and germline competency (Hirabayashi et al., 2009), could
also generate interspecific chimeras after injection into m-blas-
tocyst (middle and bottom panels in Figure S5A), but embry-
onic development rate and degree of chimerism were lower
than reported for intraspecific chimeras (Figure S5C). These
results suggest that generation of interspecific chimeras
between mouse and rat is less efficient than generation of intra-
specific chimeras.
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Figure 5. Postnatal Analysis of Interspecific
Chimeras
(A) Photograph of newborn interspecific chimeras
derived from r-blastocyst injected with miPSCs
and m-blastocyst injected with riPSCs.
(B) Neonatal body weights of interspecific
chimeras were measured and plotted. One
chimera obtained after injection of miPSCs into
r-blastocyst showed a high contribution of mouse
cells as shown in the insert, with body weight and
size equivalent to those of newborn mouse (right
panel).
(C) Photograph of interspecific chimera at 8 weeks
of age.
(D) Analysis of chimerism in neonates by organ or
tissue. Interspecific chimeras generated bymiPSC
injection into r-blastocyst (left panels) and by
riPSC injection into m-blastocyst (right panels)
are shown. Sections of representative organs
(heart, liver, pancreas, and kidney) after immunos-
taining for EGFP antibody with DAPI nuclear coun-
terstaining are shown.
(E) Neonatal pancreas and adult liver of inter-
specific chimera generated from r-blastocyst
injected with miPSC, immunostained for EGFP
and insulin or for EGFP and albumin or CK19
with DAPI nuclear counterstaining. In pancreas,
an islet-like cell cluster contains cells producing
insulin composed of both miPSC-derived cells
that express EGFP and r-blastocyst-derived cells
that do not. In liver, albumin-positive hepatocytes
and CK19-positive cholangiocytes (arrowhead)
also express EGFP, indicating miPSC origin.
(F) Distribution of xenogenic cells in neonatal testis
and in developing gonad. MVH-positive germ cells
did not express EGFP, indicating nonxenogenic
cell origin.
Sections in (D) were observed under fluorescence
microscopy and in (E) and (F) were observed under
confocal laser scanning microscopy. See also
Figure S6 for macroscopic images of neonates
and results of peripheral blood analysis of adults.
Scale bars in (A) and (B), 10 mm; in (D), 100 mm;
(E) and (F), 50 mm.Interspecific Chimeras Were Live-born; Some Grew
into Adulthood
To investigate the developmental potential of generated
chimeras and to assess the functionality of the cells, tissues, or
organs derived from injected cells, we analyzed interspecific
chimeras at neonatal and adult stages. Mouse- or rat-iPSC-
injected interspecific chimeras survivedafter birth andexpressed
EGFP ubiquitously (as did intraspecific chimeras; Figure 5A,
r-blastocyst + miPSCs: n = 5, m-blastocyst + riPSCs: n = 10).
As these chimeras developed into adulthood, chimerism could
be judged by coat color because miPSCs (C57BL/6, black
coat)were injected into r-blastocyst (Wistar,white coat) or riPSCs
(Wistar) were injected into m-blastocyst (BDF11 3 C57BL/6,black coat) (Figure 5C, r-blastocyst + miPSCs: n = 8, m-blasto-
cyst + riPSCs: n = 4). The full-term development rate of inter-
specific chimeras, either with miPSCs into r-blastocyst or with
riPSCs into m-blastocyst, was 20%. In both settings it was
lower than that for intraspecific chimeras (50%).
Determination of Body Size in Interspecific Chimeras
Adult rats typically are ten times bigger than adult mice, whereas
newborn rats are three times bigger than newborn mice.
Because mouse and rat gestations are of similar length (19 and
21 days, respectively), organogenesis requiresmore cell prolifer-
ation and differentiation during rat development than during
mouse development. What determines the size of interspecificCell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc. 793
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Figure 6. Correlation between Body Weight
and Chimerism in Interspecific Chimeras
(A) Photographs of interspecific chimeras derived
from r-blastocyst injectedwithmiPSCs, with FACS
analysis of their chimerisms in peripheral blood
mononuclear cells.
(B) Body weight change after weaning for inter-
specific chimeras (green) and their nonchimeric
littermates (orange).chimeras is an intriguing biological question. Interestingly, body
size and weight of interspecific chimeras born from rat foster
mothers were similar to those of normal newborn rats, whereas
for those born from mouse foster mothers they were similar to
those of newborn mice (Figures 5A and 5C). However, high
contributions by xenogenic cells may also affect interspecific
chimera size. One chimera obtained after injection of miPSCs
into r-blastocysts showed body weight and size equivalent to
those of a newborn mouse, although its birth mother was a rat
(Figure 5B). This particular chimera’s donor miPSC-derived cell
contribution was extremely high (Figure 5B, inlet). However,
chimeras with high contributions of xenogenic iPSC-derived
cells generally were not identified, suggesting an association
with embryonic lethality. In most chimeras, the size of newborns
seemed to conform with that in the species from which the blas-
tocyst originated. A correlation between body weight and contri-
bution of donor iPSC-derived cells as estimated from hair color
and peripheral blood cells is shown in Figure 6. The origins of
placenta and uterus may have a key role in size determination.
Injected xenogenic PSCs never developed into placenta, which
was always of host blastocyst origin (Figure 4A, Figure S5A).
Therefore it is difficult to determine whether it is placenta or
uterine environment that influences the size of embryos.
Distribution of Donor iPSC-Derived Cells
in the Xenogenic Environment
We determined the distribution of mouse- or rat-iPSC-derived
EGFP-positive cells in neonatal interspecific chimeras. With
miPSC injection into r-blastocyst (Figure S6A) and with riPSC
injection into m-blastocyst, almost all organs contained EGFP-794 Cell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc.positive cells (Figure S6B). In sections
immunostained with anti-EGFP antibody,
representative images demonstrated that
EGFP-positive cells become various
types of tissues (Figure 5D). Of particular
note was a pancreatic islet generated by
injection of miPSCs into r-blastocyst.
Cells in this islet marked immuno-
histochemically for insulin; the islet was
a composite of EGFP-positive and -nega-
tive cells, indicating that the islet con-
sisted of host rat cells and exogenous
donor mouse cells (Figure 5E). Islet poly-
clonality also was seen with intraspecific
chimeras (Figure 2E). The expression of
other functional molecules in xenogenic
cells (i.e., hepatocytes or cholangiocytesin the liver or leukocytes in the peripheral blood) was also
detected (Figure 5E and Figure S6C).
It is known that rats do not have gallbladders, whereas mice
do. To date, when mPSCs were injected into r-blastocysts, the
interspecific chimeras produced (generally the size of rats)
have not had gallbladders (n = 8). In contrast, interspecific
chimeras generated from m-blastocysts complemented with
rPSCs (more like mice in size) have had gallbladders (n = 4).
To see the xenogenic contribution to germ cells, testis and
developing gonad of the interspecific chimeras were examined.
Cells were not found that coexpressed EGFP or Venus and the
germ cell marker mouse vasa homolog (MVH) (Figure 5F). As
the injected miPSCs or rESCs were both confirmed as germ-
line-competent pluripotent stem cells in intraspecific settings
(data not shown), germ cell development may be impaired or
more limited in the xenogenic environment.
Generation of Rat Pancreas in Mouse via Interspecific
Blastocyst Complementation
Our last goal was to generate xenogenic rat pancreas in Pdx1/
mice by interspecific blastocyst complementation. For efficient
production of Pdx1/ mice, embryos were generated by inter-
cross of Pdx1/ founder male mice (in which pancreas arose
principally from exogenous miPSCs) with Pdx1+/ female mice.
With this founder system, half the mice born were Pdx1/
(in contrast to intercross of Pdx1+/ heterozygotes in which
only 25% of offspring were Pdx1/). For donor riPSCs, we
used the riPSC#3 line (Figure S4A). This line was selected among
11 established riPSC clones for embryonic developmental rate
and degree of chimerism after injection into mouse embryos
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Figure 7. Generation of Rat Pancreas in
Pdx1-DeficientMouse by Interspecific Blas-
tocyst Complementation
(A) riPSC-derived pancreas in neonatal Pdx1/
mouse. In Pdx1/ mice complemented with
riPSCs, almost all pancreata expressed EGFP,
indicating riPSC origin (top panel). On the other
hand, in Pdx1+/mice complemented with riPSCs,
pancreata only partially expressed EGFP, indi-
cating a composite of both riPSC- and mouse-
derived cells (bottom panel).
(B) Immunohistological studies of sections ob-
tained from riPSC-derived pancreas. Serial frozen
sections were immunostained for EGFP, a-
amylase, insulin, glucagon, and somatostatin
with DAPI nuclear counterstaining. See also
Figure S7 for genotyping to identify Pdx1 status
and origin of each species in interspecific chimera.
(C) Photograph of adult Pdx1/ mouse comple-
mented with riPSCs.
(D) Results of GTT in Pdx1/ (-) and Pdx1+/
(:,A) mice complemented with riPSCs.
(E) riPSC-derived pancreas in adult Pdx1/
mouse. Compare similar results of neonatal anal-
ysis (Figure 5D).
(F) Histological studies of sections obtained from
riPSC-derived adult pancreas revealed clear
differences in the distributions of riPSC-derived
cells after staining by anti-EGFP antibody with
DAPI nuclear counterstaining (right panel).
Sections were also stained with HE.
Sections in (F) were observed under light or fluo-
rescence microscopy and in (B) were observed
under confocal laser scanning microscopy. Scale
bars in (B) and (F), 100 mm.(data not shown). After injection, 139 embryos were transferred
into uteri of pseudopregnant mice and 34 mice were born.
They were analyzed at neonatal and adult stages.
The contribution of EGFP-marked riPSC-derived cells in the
pancreas of neonatal Pdx1+/ interspecific chimeras was small
relative to that of host-derived cells, as seen in whole-body
chimerism (Pdx1+/ + riPSCs in Figure 7A bottom panel; n = 5).
In contrast, the pancreatic epithelia in Pdx1/ interspecific
chimeras were entirely composed of EGFP-marked riPSC-
derived cells (Pdx1/ + riPSCs in Figure 7A top panel; n = 10).
Each genotype was confirmed by PCR using genomic DNA
extracted from FACS-sorted mouse CD45 (mCD45)-positive
splenocytes (Figure S7A). Neonates with entirely EGFP-positive
pancreata thus were clearly identified as of Pdx1/ genotype
(Figure S7B). The existence of interspecific chimeras between
mouse and rat was also confirmed by FACS patterning, which
demonstrated distinct populations of mCD45- and rat CD45
(rCD45)-positive cells, with only rCD45-positive cells expressing
EGFP after riPSC injection (Figure S7A). FACS-sorted mCD45-
and rCD45-positive cells were also confirmed as, respectively,
mouse or rat in origin by genomic PCR testing using Oct3/4
locus primers (Figure S7C), which clearly identified cell origin.
On immunostaining, riPSC-derived pancreas expressed EGFP
almost universally (Figure 7B) and also expressed a-amylase(an exocrine tissue marker) and insulin, glucagon, and somato-
statin (endocrine tissue markers; Figure 7B).
As in wild-type experiments, successful maturation into adult-
hood (8 weeks) was uncommon in Pdx1/mice complemented
with riPSCs; however, adult mice with riPSC-derived pancreas
(Figure 7C; n = 2) had intact pancreas expressing EGFP (Figures
7E and 7F). Quantitative analysis of the sections by image J soft-
ware revealed percentages of EGFP-positive cells to be 81.9% ±
3.4%. Additionally, on GTT in adulthood, insulin was secreted in
response to glucose loading and normal serum glucose levels
were maintained (Figure 7D). These results indicate that genera-
tion of a xenogenic iPSC-derived organ is possible via interspe-
cific blastocyst complementation.
DISCUSSION
We report three innovative observations, using proof-of-prin-
ciple approaches. (1) If an empty developmental niche for an
organ is provided (as with the Pdx1/mouse and the pancreatic
niche), PSC-derived cellular progeny can occupy that niche
and developmentally compensate for the missing contents of
the niche, forming an organ almost entirely composed of
cells derived from donor PSCs. (2) Generation of interspecific
chimeras between mouse and rat is possible with injection ofCell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc. 795
mouse or rat PSCs into embryos from the other species; injected
PSC-derived cells are distributed throughout the body and
appear to function normally. (3) The combination of (1) and (2)
successfully generates rat pancreas in mouse with injection of
riPSCs into Pdx1/ mouse embryos, a technique that we term
‘‘interspecific blastocyst complementation.’’
We demonstrated that the Pdx1/ mice derived from blasto-
cysts complemented with mPSCs were born with functional
pancreas almost entirely derived from donor PSCs and grew
into adulthood without showing any evidence of pancreatic
insufficiency. Several groups have used the same technique to
study the development of thymic epithelium (Muller et al.,
2005), to compensate for cardiac defects (Fraidenraich et al.,
2004), or to determine if yolk sac hematopoiesis and germ cell
development are of clonal or nonclonal origin (Ueno et al.,
2009; Ueno andWeissman, 2006). Although Stanger et al. tested
development of pancreas and liver in embryos to define organ
size determinants (Stanger et al., 2007), no study has exploited
this technique to produce donor-derived functional organs and
rescued a lethal phenotype to adulthood.
Direct in vitro differentiation of insulin-producing cells from
PSCs has been a major focus of stem cell therapy, as recently
demonstrated by a sophisticated protocol to generate pancre-
atic endoderm efficiently via stepwise endodermal differentia-
tion (Kroon et al., 2008). However, the in vitro generation
of insulin-producing cells still needs further improvement in
differentiation efficiency, in insulin production levels, or in speed
of insulin response to glucose changes. In addition, the risk
of tumor development due to contamination with undifferenti-
ated PSCs must be rigorously assessed before clinical use.
Compared with those generated in vitro, insulin-producing cells
obtained from pancreas that is formed in vivo by blastocyst
complementation must have gone through near-normal differ-
entiation processes with proper epigenetic changes. The
tissues obtained, such as insulin-producing cells, thus are
presumed to be fully functional and the risk of teratoma devel-
opment due to contamination of undifferentiated PSCs to be
negligible. Nonetheless, the oncogenicity of iPSC-derived cells
due to reactivation of introduced genes (Miura et al., 2009;
Nakagawa et al., 2008) or to genome abnormality due to long-
term culture remains to be assessed. To establish iPSCs without
genomic integration of a retroviral sequence should further
reduce the risk associated with the use of iPSCs (Okita et al.,
2008).
We assumed that aggregation of early embryos would lead
to the presence in trophectoderm of xenogenic cells that are
reported to be harmful to embryonic development after uterine
implantation. We therefore injected mESCs/iPSCs, but not blas-
tomere cells, into r-blastocysts. As predicted, EGFP-positive
PSC-derived cells were not detected in placentas (Figure 4A
and Figure S5A), and we succeeded in generating interspecific
chimeras. To confirm this further, we then attempted to generate
interspecific chimeras by injecting rESCs/iPSCs into m-blasto-
cysts. After injection into 8-cell/morula stage mouse embryos,
the riPSCs were eventually enclosed within the inner cell mass
of the m-blastocyst and were never detected in them-blastocyst
trophectoderm (Figures S4C and S4D). Our study, consistent
with others, indicates that the presence of xenogenic cells796 Cell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc.among extraembryonic lineage cells, with exposure of xeno-
genic cells to the uterine environment, is inhibitory to implanta-
tion and/or to further intrauterine development of interspecific
chimeras.
It is of prime interest that body size and weight of interspecific
chimeras conformed with those of the species of the foster
mother (Figures 5A–5C).What xenogenic components contribute
to the phenotypic determination of interspecific chimeras?
It seems that placenta and/or uterine environment are respon-
sible for size determination of adult interspecific chimeras
both as embryos and as adults. Given that placenta must be of
the same origin as the foster mother for successful generation
of interspecific chimeras, it is not clear which is primarily respon-
sible for this determination. Degree of chimerism may also
influence the phenotype. As observed in intraspecific chimeras,
contribution and distribution of xenogenic cells in interspecific
chimeras vary organ-to-organ. There is a negative correlation
between contribution of donor (mouse) PSC-derived cells and
body weight (Figure 6). Although we could obtain interspecific
chimeras consistently (Figure 4 and Figure 5), embryonic lethality
was high and postnatal development was poor. Some interac-
tions between mouse- and rat-derived cells indispensable
for organism survival may not work across species, resulting in
death during embryonic development or in retarded postnatal
development.
Another example is the formation of gallbladders in inter-
specific chimeras. Those derived from m-blastocysts have
gallbladders but those from r-blastocysts do not. It is conceiv-
able that the temporo-spatial development of donor PSC-
derived cells is regulated by the xenogenic host microenviron-
ment, which governs morphogenesis and organogenesis.
However, the data also indicate that the intrinsic develop-
mental program imprinted in PSCs may create competition
between host blastocyst-derived and donor PSC-derived cells
to form chimeric organs. The balance between host and donor
cells at certain critical points during embryonic development
thus may be important. Xenogenic developmental systems
may be useful to elucidate these and other developmental
questions and to help in generation of chimeras between
species evolutionarily more distant from one another than
are mouse and rat.
Most importantly, we succeeded in generating functional rat
pancreas in Pdx1/ mice via interspecific blastocyst comple-
mentation. In all interspecific neonates derived from Pdx1/
blastocysts injected with riPSCs, pancreas was present.
Although full maturation into adulthood was not common, once
the mice matured into adulthood, the generated riPSC-derived
pancreas was morphologically and histologically normal and
was not associated with any sign of diabetes or other abnormal-
ities; GTT results strongly indicated normal function. Generation
of functional cells (sperm, hepatocytes) in xenogenic environ-
ments has been reported (Mercer et al., 2001; Shinohara et al.,
2006). In addition, hematopoietic xeno-chimeras have been
used commonly as amethod to study functionality of hematopoi-
etic stem cells (Kamel-Reid and Dick, 1988; McCune et al.,
1988). No study, however, has demonstrated generation in
a xenogenic environment of a PSC-derived functional organ
that can rescue embryonic lethality to adulthood.
The organ generation system described may be applied to
treat organ failure in humans if pigs or other large animals are
used. There are, however, several issues that need to be
addressed to bring this principle into the clinic. For example,
thoughwewere able to generate interspecific chimeras between
mouse and rat, their embryonic lethality is high and maturation
into adulthood is uncommon. The nature of this xenogenic barrier
is not clear, but it is evident that the evolutionary distance
accounts for this, aswedonot see theseproblems in intraspecific
chimeras. Livestock animals such as pigs or sheep may be too
distant evolutionarily for successful complementation. In addi-
tion, as described in the allogenic system, vessels, nerves, and
some interstitial elements that are not under the influence of
Pdx1 expression were composites of host- and miPSC- or
mESC-derived cells. Although we showed in this study that islets
prepared from miPSC-derived pancreas generated in allogenic
hosts indeed were successfully transplanted into ‘‘autologous’’
mice with STZ-induced diabetes without rejection, whether the
same principle applies to transplantation of islets obtained from
pancreas generated in xenogenic animals remains to be seen.
Transplantation of islets from rat pancreas generated in Pdx1/
mice into diabetic rats should answer this question. However,
due to the size difference between mouse and rat, and to high
embryonic lethality andpoor postnatalmaturation of interspecific
chimeras, it is not possible to obtain sufficient numbers of islets to
treat diabetic rats. Generation ofmouse pancreas inPdx1/ rats
will be necessary to do such experiments.
Production of organ-deficient livestock animals and genera-
tion of chimeras is another issue, but nuclear transfer technology
available for livestock animals may permit establishment of
organ-deficient pig lines, for example (Lai et al., 2002). The
successful generation of pig chimeras using blastocyst injection
has also been reported (Nagashima et al., 2004). The major diffi-
culty seems to be that primate and rodent PSCs differ (Nichols
and Smith, 2009); limits of primate PSCs in contributing to
embryo development have been suspected. Poor contribution
of human ESCs to embryo development after injection into
mouse blastocysts or chick embryo has been demonstrated
(Goldstein et al., 2002; James et al., 2006). Generation of inter-
specific chimera technology may prove a tool useful in assess-
ment of pluripotent stem cell potential, thereby addressing this
issue.
Another issue of concern is the fact that PSC-derived cells
are found not only in pancreas but in all organs and tissues,
including brain and gonads. Therefore, without proper control
of the differentiation potential of PSCs, generation of human
organs in livestock animals will face an ethical issue. There are
several approaches to address this. One is use of committed
stem or progenitor cells in place of PSCs. If they are introduced
into an appropriate microenvironment at an appropriate devel-
opmental time point, to restrict differentiation toward a particular
organ may be possible. An alternative is to use genetically modi-
fied PSCs whose differentiation potential is restricted to certain
tissues or organs.
In conclusion, the approach described here will be of use not
only for better understanding of the mechanism of organogen-
esis but also as an initial step toward the ultimate regenerative
medicine of the future.EXPERIMENTAL PROCEDURES
Animals
C57BL/6NCrSlc, BDF1, DBA/2CrSlc, ICR mice, and Wistar rats were
purchased from SLC Japan (Shizuoka, Japan). Pdx1-LacZ heterozygous
mice (Offield et al., 1996), kindly provided by Dr. Y. Kawaguchi (Kyoto
University) and Dr. C.V. Wright (Vanderbilt University), were crossed with
C57BL/6, DBA2, or BDF1 strain mice. C57BL/6 mice were given STZ (Sigma,
St. Louis, MO, USA) to induce diabetes. Mice with nonfasting blood glucose
levels > 400mg/dL 1week after STZ administration (200mg/kg) were regarded
as hyperglycemic and thus as diabetic mice. All experiments were performed
in accordance with the animal care and use committee guidelines of the Insti-
tute of Medical Science, University of Tokyo.
Culture of ESCs/iPSCs
Undifferentiated mESCs were maintained on gelatin-coated dishes without
feeder cells in Glasgow’s modified Eagle’s medium (Sigma) supplemented
with 10% fetal bovine serum (FBS; Nichirei Bioscience, Tokyo, Japan),
0.1 mM 2-mercaptoethanol (Invitrogen, San Diego, CA, USA), 0.1 mM nones-
sential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 1%
L-glutamine penicillin streptomycin (Sigma), and 1000U/ml of mouse leukemia
inhibitory factor (LIF; Millipore, Bedford, MA, USA). The G4.2 mESCs and
EB3DR mESCs, kindly provided by Dr. H. Niwa (Center for Developmental
Biology, RIKEN), were derived from EB3mESCs (Niwa et al., 2000) and carried
the CAG promoter-driven EGFP or DsRed gene. Undifferentiated miPSCs
were maintained on mitomycin-c treated mouse embryonic fibroblasts
(MEFs) in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented
with 15% knockout serum replacement (Invitrogen), 0.1 mM 2-mercaptoetha-
nol, 0.1 mM nonessential amino acids, 1 mM HEPES buffer solution (Invitro-
gen), 1% L-glutamine penicillin streptomycin, and 1000 U/ml of mouse LIF.
The GT3.2 miPSCs were generated from TTFs of a male EGFP Tg mouse
(kindly provided by Dr. M. Okabe, Osaka University) by introducing three
factors (Klf4, Sox2, Oct3/4) in retroviral vectors (Okabe et al., 2009). The
GT3.2 miPSCs ubiquitously express EGFP under the control of the CAG
promoter.
Undifferentiated rESCs/iPSCs were maintained on mitomycin-c treated
MEFs in N2B27 medium (Ying et al., 2003) containing 1 mM MEK inhibitor
PD0325901 (Axon Groeningen, The Netherlands), 3 mM GSK3 inhibitor
CHIR99021 (Axon), with or without FGF receptor inhibitor SU5402 (Calbio-
chem, La Jolla, CA, USA), and 1000 U/ml of rat LIF (Millipore). The riPSCs
were generated from Wistar rat embryonic fibroblast by introducing three
mouse factors (Oct3/4, Klf4, Sox2) in lentiviral vectors as a doxycycline-induc-
ible expression unit using N2B27 medium containing the three inhibitors
described above. Expression of representative ESC marker genes has been
confirmed and teratoma formation by these riPSCs after injection into immu-
nodeficient mice has also been confirmed (our unpublished data). The riPSCs
ubiquitously express EGFP under the control of the Ubiquitin-C promoter.
The WIv3i-1 or WIv3i-5 rESCs were generated from Venus Tg rat blastocyst
(Hirabayashi et al., 2009). These rESCs ubiquitously express Venus under
the control of the CAG promoter.
Embryo Culture and Manipulation
Preparation of wild-type or Pdx1 heterozygous intercrossing embryos was
carried out according to published protocols (Nagy et al., 2003). In brief,
mouse 8-cell/morula stage embryos were collected in Medium 2 (Millipore)
from oviduct and uterus of mice 2.5 days postcoitum (dpc). These embryos
were transferred into potassium simplex optimized medium with amino acids
(Millipore) and were cultured for 24 hr for blastocyst injection.
Rat blastocysts were collected in a bicarbonate-buffered medium
composed of Roswell Park Memorial Institute medium (RPMI) 1640, Eagle’s
solution, and Ham’s F12 containing 18% FBS medium (Ogawa et al., 1971)
from oviduct and uterus of rats 4.5 dpc. These embryos were transferred
into modified rat 1-cell embryo culture medium (Oh et al., 1998) containing
80 mM NaCl (Wako Pure Chemical Industries, Osaka, Japan) and 0.1% poly-
vinyl alcohol (Sigma) and were cultured for about 1 hr until injection.
For micromanipulation, ESCs or iPSCs were trypsinized and suspended in
ESC or iPSC culture medium. A piezo-driven micromanipulator (Prime Tech,Cell 142, 787–799, September 3, 2010 ª2010 Elsevier Inc. 797
Tokyo, Japan) was used to drill zona pellucida and trophectoderm under the
microscope and 10–15 ESCs or iPSCswere introduced into blastocyst cavities
near the inner cell mass. After blastocyst injection, embryos underwent follow-
up culture for 1–2 hr. Mouse blastocysts then were transferred into the uteri
of pseudopregnant recipient ICR female mice (2.5 dpc) and rat blastocysts
were transferred into the uteri of pseudopregnant recipient Wistar female
rats (3.5 dpc).SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at doi:10.1016/j.cell.
2010.07.039.
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